Home
>
US Stocks
>
Cogent Biosciences Inc
Cogent Biosciences Inc
COGT

Cogent Biosciences Inc (COGT)

$8.22.5%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
8.2
Today Low/High
8.11 / 8.22
52 Week Low/High
$2.05 / $14.44
Market Cap
$319.96M

Company Details

Cogent Biosciences is a biotechnology company focused on developing precision therapies for genetically defined diseases. The most advanced clinical program, PLX9486, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling. Cogent Biosciences is headquartered in Cambridge, MA.
Organisation
Cogent Biosciences Inc
Employees
15
Industry
Health Technology

Discover more

Frequently Asked Questions

What is Cogent Biosciences Inc (COGT) share price today?

Can Indians buy Cogent Biosciences Inc (COGT) shares?

How can I buy Cogent Biosciences Inc (COGT) shares from India?

Can Fractional shares of Cogent Biosciences Inc (COGT) be purchased?

What are the documents required to start investing in Cogent Biosciences Inc (COGT) stocks?

We are a SEBI registered investement advisor